The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series

Anal cancer patients who have exhibited disease progression after having received all approved drugs pose a major therapeutic challenge. In addition to cytotoxic agents, novel targeted agents are being developed and have an established role in the treatment of many solid tumors, including colon canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Saif, Muhammad W., Kontny, Ewa, Syrigos, Kostas N., Shahrokni, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136097/
https://www.ncbi.nlm.nih.gov/pubmed/21772841
http://dx.doi.org/10.1155/2011/125467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136097/
https://www.ncbi.nlm.nih.gov/pubmed/21772841
http://dx.doi.org/10.1155/2011/125467

Ejemplares similares